Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
MW8FAVQ3dq9ZJmHs
